AI driven drug discovery requires more data from various sources, independent predictions and strategic rules than ever considering its data centric characteristics. Molecule design using generative models, activity prediction, property calculation, data processing, analytics, machine learning and web service deployment are all required for production-level protocols in early drug discovery projects. MolFactory is the proprietary system developed by Standigm to generate optimized molecules to meet this expectation with scalable and distributed system architecture. It is being used to generate not only early virtual hit compounds which are very novel, active to specific target protein, and of desirable drug-likeness but also visual reporting with automatic and scalable way.

MolFactory: Standigm integrated AI drug discovery platform

Macromolecular Chemistry: The Second Century

[Author Benefits](https://scimeetings.acs.org/?utm_source=pubs_content_marketing&utm_medium=website&utm_campaign=0320_MCF_NPI_Launch_Spring_Homepage&ref=pubs_content_marketing)

[How to use SciMeetings](https://storage.googleapis.com/dl.morressier.com/acs/SciMeetings-ACSSpring2020-HowToGuide_M3020-Final.pdf)

[Frequently Asked Questions](https://storage.googleapis.com/dl.morressier.com/acs/SciMtng_ACSNMSp2020_FAQ_M3120_Final.pdf)

ACS Spring 2020 National Meeting & Expo

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.